Skip to main content
Veterinary Medicines

DEPOCILLIN 300MG/ML ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ

Authorised
  • Benzylpenicillin procaine

Product identification

Medicine name:
DEPOCILLIN 300MG/ML ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
  • Benzylpenicillin procaine
Target species:
  • Cattle
  • Horse
  • Goat
  • Pig
  • Sheep
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Benzylpenicillin procaine
    300.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        6
        day
      • Milk
        11
        day
    • Horse
    • Goat
      • Meat and offal
        6
        day
      • Milk
        11
        day
    • Pig
      • Meat and offal
        4
        day
    • Sheep
      • Meat and offal
        4
        day
      • Milk
        11
        day
    • Dog
      • Not applicable
        no withdrawal period
    • Cat
      • Not applicable
        no withdrawal period
  • Subcutaneous use
    • Dog
      • Not applicable
        no withdrawal period
    • Cat
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CE09
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet Hellas A.E.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Productions S.r.l.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 70390/18-10-2010/K-0060601
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."